ATECNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Alphatec Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$10.41−0.05 (-0.48%)
Close on Oct 19, 2026
- Market cap
- $1.63B
- P/E (TTM)
- –
- Dividend yield
- –
Alphatec Holdings, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $763.53M | $737.39M | $716.14M | $681.72M | $639.15M | $600.53M | $571.27M | $535.68M | $503.97M | $475.23M | $445.35M | $414.71M | 93.7% | +19.5% |
| International | $51.52M | $49.69M | $48.01M | $46.30M | $43.08M | $41.73M | $40.30M | $37.06M | $36.31M | $36.40M | $36.91M | $35.53M | 6.3% | +19.6% |
From the segment and revenue-disaggregation notes of Alphatec's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.